Quality & complianceOfficial

Denmark flags amoxicillin vet tablet shortage from Ceva Animal Health until early 2027

🇩🇰 DKMA · Thu 05 Nov 2026

The Danish Medicines Agency reports production problems affecting Amoxival Vet. 200 mg tablets (20-pack), with supply expected to be disrupted from early November 2026 to early January 2027.

The Danish Medicines Agency (DKMA) has published a supply notice for Amoxival Vet. 200 mg tablets in packs of 20, a veterinary antibiotic marketed by Ceva Animal Health A/S. The notice is dated 5 November 2026 and refers to current supply problems.

The active substance is amoxicillin, classified under ATC code QJ01CA04. DKMA gives the cause as production problems. The expected period of disruption runs from the start of November 2026 to the start of January 2027.

The agency does not name alternative products in the notice, and it gives no details on the nature of the manufacturing issue. Questions about the current status should be directed to the company, DKMA says, which also points readers to its general page of notices on medicine supply.

As general context, national regulators publish supply notices of this kind to give prescribers, pharmacies and distributors advance warning of shortages. The dates given are expectations and may change.

What it means for your team

  • Companies and veterinary prescribers in Denmark should plan for limited availability of Amoxival Vet. 200 mg (20 tablets) from November 2026 to early January 2027.
  • Supply-chain and market-access teams should confirm current stock status directly with Ceva Animal Health A/S, as DKMA refers status questions to the company.
  • DKMA gives production problems as the cause but does not specify the issue or recommend alternatives, so teams should not assume any substitution guidance.

Official source: DKMA ↗

Article written by VigiEye from the official source (DKMA). AI-assisted; check the source before acting.

More Quality & compliance All →